Sun Lays Out Halol Compliance Plan As Results Trounce Forecasts

India’s Sun Pharma has surprised investors with a strong leap in profit and it says it will lodge a request by the end of June with the US FDA to re-inspect its troubled Halol plant, in the first official indication of a likely timeline for the restoration of compliance at the facility.